Key result
Highest TyG-WHtR quartile linked to ~87% greater incident multimorbidity risk.
Why the study?
The association of triglyceride-glucose waist-to-height ratio with generalized multimorbidity across populations and its dose-response threshold remained uncertain.
Does a higher triglyceride-glucose waist-to-height ratio predict prevalent and incident multimorbidity in adults aged ≥ 50 years?
Observational (n=12,547)
Yes
Does a higher triglyceride-glucose waist-to-height ratio predict prevalent and incident multimorbidity in adults aged ≥ 50 years?
Higher TyG-WHtR is significantly associated with prevalent and incident multimorbidity across multiple national cohorts, suggesting a potential risk-alert interval of 5-7 for early identification.
Suggests this novel metabolic index may identify adults at risk for generalized multimorbidity; leaves open whether.
Background The triglyceride-glucose waist-to-height ratio (TyG-WHtR) integrates insulin resistance and central adiposity, but its association with generalized multimorbidity across populations and its dose–response threshold remain uncertain. Methods We analyzed adults aged ≥ 50 years from five analytic samples derived from four national studies. Cross-sectional analyses included the National Health and Nutrition Examination Survey (NHANES; n = 1842) and the Health and Retirement Study (HRS; n = 4310), whereas prospective analyses included the China Health and Retirement Longitudinal Study (CHARLS; n = 4114), the English Longitudinal Study of Ageing (ELSA; n = 1310), and HRS (n = 971). Multimorbidity was defined as the presence of at least two of eight harmonized chronic conditions. Multivariable logistic regression and Cox proportional hazards models were used to evaluate prevalent and incident multimorbidity, respectively. Restricted cubic spline and two-piecewise regression models were used to assess nonlinear associations, and receiver operating characteristic curves were used to compare TyG-WHtR with five alternative TyG-related anthropometric indices. Results In the cross-sectional analyses, the fully adjusted ORs comparing the highest with the lowest TyG-WHtR quartile were 5.04 (95% CI 3.02–8.42) in NHANES and 3.63 (95% CI 2.70–4.90) in HRS. In the prospective analyses, the fully adjusted HRs comparing the highest with the lowest quartile were 1.87 (95% CI 1.59–2.21) in CHARLS, 1.67 (95% CI 1.30–2.15) in ELSA, and 1.57 (95% CI 1.08–2.29) in HRS. Prospective dose–response associations were nonlinear, with inflection points of 5.92, 5.80, and 6.69, respectively; risk increased predominantly below these values. TyG-WHtR had the largest area under the curve in both cross-sectional samples and in CHARLS and ELSA. Lagged analyses and alternative multimorbidity definitions yielded consistent results. Conclusions Higher TyG-WHtR was associated with prevalent multimorbidity in both cross-sectional samples and with incident multimorbidity in quartile-based analyses across all three prospective cohorts, although the continuous association was not statistically significant in prospective HRS. The cohort-specific inflection points suggest a provisional candidate risk-alert interval of approximately 5–7. This interval requires independent external validation and should not be interpreted as a diagnostic or treatment threshold.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2026) conducted an observational in Multimorbidity (n=12,547). Triglyceride-glucose waist-to-height ratio (TyG-WHtR) vs. Lowest quartile of TyG-WHtR was evaluated on Incident multimorbidity (presence of at least two of eight harmonized chronic conditions) (HR 1.87, 95% CI 1.59-2.21). Higher triglyceride-glucose waist-to-height ratio was significantly associated with an increased risk of incident multimorbidity, with the highest quartile showing an 87% increased risk (HR 1.87) in the CHARLS cohort.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: